UroGen Pharma (URGN) Debt Ratio (2022 - 2026)

UroGen Pharma (URGN) has 5 years of Debt Ratio data on file, last reported at 0.75 in Q1 2026.

• Quarterly Debt Ratio rose 51.5% year-over-year to 0.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.75 (up 51.5% YoY) and the FY2025 annual result came in at 0.61, up 43.09% from the prior year.
• Debt Ratio rose to 0.75 in Q1 2026, from 0.61 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.03 in Q2 2023 to a low of 0.35 in Q2 2024.
• A 5-year average of 0.58 and a median of 0.55 in 2023 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2023 — Debt Ratio soared 111.58% — and 2024, when it tumbled 66.33%.
• Tracing URGN's Debt Ratio over 5 years: stood at 0.72 in 2022, then declined by 23.15% to 0.55 in 2023, then fell by 22.91% to 0.43 in 2024, then jumped by 43.09% to 0.61 in 2025, then climbed by 22.54% to 0.75 in 2026.
• The last three Debt Ratio figures came in at 0.75 (Q1 2026), 0.61 (Q4 2025), and 0.66 (Q3 2025), per Business Quant data.